This paper describes preparation and biological evaluation of pyrazinamide analogues. Pyrazinamide with its simple structure gives a good opportunity for further modification regarding an increase of its antimycobacterial activity. We prepared a series of compounds derived from pyrazine‐2,5‐dicarbonitrile with arylamino substitution in position 3. All compounds were assayed in vitro against major Mycobacterium